Miglustat
Records for this ingredient, by country (identity only).
ATC A16AX06 · 8 markets · 41 records
US 7 records · 2 shown of 2
GB 7 records · 2 shown of 2
FR 7 records · 2 shown of 2
- 100 mgcapsuleMIGLUSTAT ACCORD 100 mg, géluleMIGLUSTAT BLUEFISH 100 mg, gélule、MIGLUSTAT DIPHARMA 100 mg, gélule、MIGLUSTAT GEN.ORPH 100 mg, gélule、YARGESA 100 mg, gélule、ZAVESCA 100 mg, gélule
- 65 mgcapsuleOPFOLDA 65 mg, gélule
ES 6 records · 2 shown of 2
- 100 mgcapsuleMIGLUSTAT ACCORDMIGLUSTAT DIPHARMA、MIGLUSTAT GEN.ORPH、Yargesa、Zavesca
- 65 mgcapsuleOPFOLDA
EU 5 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
AU 4 records · 2 shown of 2
- 100 mgcapsuleZAVESCA miglustat 100 mg capsules blister pack
- 65 mgcapsuleOPFOLDA miglustat 65 mg capsule bottle
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 3 records · 2 shown of 2
- 100 mgcapsuleSANDOZ MIGLUSTATZavesca
- 65 mgcapsuleOPFOLDA
TW 1 records · 1 shown of 1
- 100 mgcapsuleZAVESCA hard capsule 100mg澤維可膠囊100毫克
| Strength / form / release | US | GB | CA | AU | ES | TW | EU | FR |
|---|---|---|---|---|---|---|---|---|
| 100 mg capsule | Manufacturer: ANI Pharmaceuticals, Inc. Manufacturer: CoTherix, Inc. Manufacturer: Navinta LLC | Manufacturer: A A H Pharmaceuticals Ltd Manufacturer: Accord-UK Ltd Manufacturer: Flynn Pharma Ltd | SANDOZ MIGLUSTAT Zavesca | ZAVESCA miglustat 100 mg capsules blister pack | MIGLUSTAT ACCORD MIGLUSTAT DIPHARMA MIGLUSTAT GEN.ORPH | ZAVESCA hard capsule 100mg 澤維可膠囊100毫克 | MIGLUSTAT ACCORD 100 mg, gélule MIGLUSTAT BLUEFISH 100 mg, gélule MIGLUSTAT DIPHARMA 100 mg, gélule+3MIGLUSTAT GEN.ORPH 100 mg, gélule YARGESA 100 mg, gélule ZAVESCA 100 mg, gélule | |
| 65 mg capsule | OPFOLDA | OPFOLDA | OPFOLDA | OPFOLDA miglustat 65 mg capsule bottle | OPFOLDA | OPFOLDA 65 mg, gélule | ||
unknown | OPFOLDA Zavesca | MIGLUSTAT DIPHARMA MIGLUSTAT GEN.ORPH OPFOLDA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in AU · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en AU · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 AU · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 AU · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
migALAstat） FDA recommends tall-man lettering for this pair; check the ingredient, not the name. All pairsDiscontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.